Probio Inc.

Pennington, NJ Genscript Probio USA Inc.

UEI
GZHYAK6ABHW7
CAGE
9BQX1
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
ProBio Inc, Hopewell Facility, 311 Pennington Rocky Hill Rd Building 9, Pennington, NJ 08534, USA
Website
genscriptprobio.com
Founded
2002
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Probio Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Nichd - economy gene synthesis Contract · 75N94022P00594 National Institute of Child Health and Human Development $0
Antibody production, purification and testing services Contract · 75N93022P00942 National Institute of Allergy and Infectious Diseases $35,088

About Probio Inc.

Genscript Probio USA Inc. is a corporate entity registered in SAM.gov as a self-certified small disadvantaged business and for-profit organization located in Piscataway, New Jersey. The company appears to specialize in biotechnology and scientific research services, with a focus on advanced biological research techniques such as gene synthesis, antibody production, and related scientific testing. While specific details about the company's full corporate background are not provided, the vendor's federal contract registration indicates a professional orientation toward specialized scientific and research-oriented services for federal agencies.

The company has secured federal contract awards from multiple National Institutes of Health agencies, specifically the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases. Its contract work has included specific projects like economy gene synthesis and antibody production, purification, and testing services. The federal contract awards have been structured as purchase orders, with one notable sub-contract award from Mriglobal involving production of a primary cell bank and plasmid DNA drug substance scheduled for November 2024. The contract awards demonstrate Genscript Probio USA Inc.'s capability to perform complex scientific research and development services for federal agencies, with contract values ranging up to $35,088.00, and no specific set-aside designations applied to the awards.

Quick answers

What is Probio Inc.'s UEI?

Probio Inc.'s Unique Entity ID (UEI) in SAM.gov is GZHYAK6ABHW7.

What is Probio Inc.'s CAGE code?

Probio Inc.'s CAGE code is 9BQX1.

What is Probio Inc.'s primary NAICS code?

Probio Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).

Where is Probio Inc. located?

Probio Inc.'s physical address in SAM.gov is ProBio Inc, Hopewell Facility, 311 Pennington Rocky Hill Rd Building 9, Pennington, NJ 08534, USA.

Is Probio Inc. registered in SAM.gov?

Yes. Probio Inc.'s SAM.gov registration is active through March 27, 2027.

What is Probio Inc.'s most recent federal award?

Probio Inc.'s most recent federal contract award is Nichd - economy gene synthesis (75N94022P00594), from National Institute of Child Health and Human Development, on August 7, 2022.

On GovTribe

See Probio Inc.'s full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors